• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cronson Paul C converted options into 5,557 shares and returned $437,672 worth of shares to the company (210,419 units at $2.08), closing all direct ownership in the company (SEC Form 4)

    10/19/23 9:55:42 PM ET
    $EMAN
    Industrial Machinery/Components
    Technology
    Get the next $EMAN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
    X
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    CRONSON PAUL C

    (Last) (First) (Middle)
    700 SOUTH DRIVE
    SUITE 201

    (Street)
    HOPEWELL JUNCTION NY 12533

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    EMAGIN CORP [ EMAN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    10/18/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 10/18/2023 M(1)(2) 5,557 A (2) 210,419 D
    Common Stock 10/18/2023 D(1)(3) 210,419 D $2.08(3) 0 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (2) 10/18/2023 M(1)(2) 5,557 (2) (2) Common Stock 5,557 $0 0 D
    Stock Option (Right to Buy) $1.65 10/18/2023 D(1)(4) 38,509 (4) 01/17/2025 Common Stock 38,509 (4) 0 D
    Stock Option (Right to Buy) $1.8 10/18/2023 D(1)(4) 34,946 (4) 07/01/2028 Common Stock 34,946 (4) 0 D
    Stock Option (Right to Buy) $0.92 10/18/2023 D(1)(4) 73,915 (4) 01/03/2026 Common Stock 73,915 (4) 0 D
    Stock Option (Right to Buy) $0.47 10/18/2023 D(1)(4) 150,818 (4) 07/02/2029 Common Stock 150,818 (4) 0 D
    Stock Option (Right to Buy) $0.83 10/18/2023 D(1)(4) 25,000 (4) 07/06/2030 Common Stock 25,000 (4) 0 D
    Stock Option (Right to Buy) $0.73 10/18/2023 D(1)(4) 45,000 (4) 06/10/2032 Common Stock 45,000 (4) 0 D
    Series B Convertible Preferred Stock (4) 10/18/2023 D(1)(5) 120 (5) (5) Common Stock 397,088 (5) 0 I See footnote(6)
    Explanation of Responses:
    1. This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2023, by and among the Issuer, Samsung Display Co., Ltd. ("Parent"), Emerald Intermediate, Inc., a wholly owned subsidiary of Parent ("Silk USA"), and Emerald Merger Sub, Inc., a wholly owned subsidiary of Silk USA ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger") effective as of October 18, 2023 (the "Effective Time") with the Issuer surviving the Merger as a wholly owned subsidiary of Parent.
    2. At the Effective Time, each then-outstanding restricted stock unit ("RSU") award held by the Reporting Person became fully earned and vested with respect to the maximum number of shares underlying such RSU award.
    3. At the Effective Time, each share of Common Stock held by the Reporting Person immediately prior to the Effective Time was converted into the right to receive $2.08 in cash, without interest.
    4. At the Effective Time, each then-outstanding option to purchase Common Stock that had a per share exercise price that was less than $2.08 (each, an "In-the-Money Option") was cancelled and converted into the right to receive an amount in cash equal to the product of (I) the excess, if any, of $2.08 over the applicable exercise price per share of Common Stock subject to such cancelled In-the-Money Option multiplied by (II) the aggregate number of shares of Common Stock subject to such In-the-Money Option immediately prior to the Effective Time.
    5. At the Effective Time, each share of Series B Convertible Preferred Stock issued and outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive cash, without interest, in an amount equal to (x) the total number of shares of Common Stock issuable upon conversion of the Series B Convertible Preferred Stock that are owned immediately prior to the Effective Time, multiplied by (y) $2.08, without interest.
    6. The Reporting Person has an indirect pecuniary interest in the securities held by Navacorp III LLC. The Reporting Person exercises the sole voting power with respect to the shares held in the name of Navacorp III LLC.
    /s/ Mark A. Koch, as Attorney-in-Fact 10/19/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $EMAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EMAN

    DatePrice TargetRatingAnalyst
    3/16/2023$3.00Buy
    Ladenburg Thalmann
    More analyst ratings